Exercise for Elderly Lymphoma Patients

Exercise Training is a Feasible and Active Complementary Therapy in Adult and Elderly Patients Receiving Anti- Lymphoma Treatments

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04259593

Enrollment

Registered

2020-02-06

Start date

2016-01-02

Completion date

2018-05-31

Last updated

2020-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly Lymphoma Patients

Keywords

Exercise training, Complementary therapy

Brief summary

This pilot study was designed in a real-life setting to establish the feasibility, the safety and the activity of a supervised and combined Exercise Training (ET) program in adult and elderly lymphoma patients undergoing cancer-treatments.

Detailed description

Eligible patients were assigned to the ET group. All the patients eligible for exercise but not partiticpating to the ET program because of logistical reasons, were considered as the control group. All clinical outcomes were assessed before exercise training (T0), 3 (T1) and 6-months (T2) after the beginning of the exercise.

Interventions

OTHERexercise training

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* ≥18-80 years old, histologically conﬁrmed HL or NHL, patients in need of first or subsequent lines of systemic treatment and with a long-life expectancy

Exclusion criteria

* Patients were excluded if they had less than 4 months of anti-cancer treatment to be delivered, severe orthopaedic, cardiac, pulmonary, or cognitive impairment, osteolytic lesions with the risk of fracture, cachexia or if they were ≥ 65 years and frail on the basis of comprehensive geriatric assessment

Design outcomes

Primary

Measure	Time frame	Description
The eligibility rate	6 months	the eligibility rate was assessed by the number of eligible patients divided by the total number of elements on the sampling frame.
The recruitment rate	6 months	the recruitment rate was assessed by the number of patients included in the study divided by the total number of eligible patients
The exercise adherence rate	4 months	The exercise adherence rate was assessed by the number of exercise sessions attended out of the 48 sessions scheduled for each patient
The assessment rate	6 months	The assessment rate was assessed by the number of patients who completed the T1 and T2 follow-up times over the total number who participated in the study
Safety of the exercise training	6 months	Safety was assessed by monitoring any serious adverse events that occured during the ET period.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026